Biotinylated Anti-CLEC4C (litifilimab biosimilar) mAb

Biotinylated Anti-CLEC4C (litifilimab biosimilar) mAb
Artikelnummer
DMABME100155B-50
Verpackungseinheit
50 µg
Hersteller
DIMA Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: Biotinylated Anti-CLEC4C (litifilimab biosimilar) mAb

Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Formulation & Reconstitution: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.

Target: CLEC4C

Uniprot ID: Q8WTT0

Usage: Research use only

Recommended Dilutions: ELISA 1:5000-10000 Flow Cyt 1:100

Common Name: BIIB 059, BIIB-059, BIIB059
Mehr Informationen
Artikelnummer DMABME100155B-50
Hersteller DIMA Biotechnology
Hersteller Artikelnummer BME100155B-50
Verpackungseinheit 50 µg
Mengeneinheit STK
Reaktivität Human
Methode ELISA, Flow Cytometry
Isotyp IgG1(E239D, M241L)
Wirt Human
Konjugat Conjugated, Biotin
Produktinformation (PDF) Download
MSDS (PDF) Download